drugset / Trial / NCT02965456

Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

NCT02965456

Phase 3 Completed 820 enrolled Bausch Health Americas, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study was to evaluate the efficacy, safety, and tolerability of a once daily topical application of IDP-121 Lotion compared with its vehicle (IDP-121 Vehicle Lotion) in participants with moderate to severe acne vulgaris (acne) (that is, acne having an Evaluator's Global Severity Score \[EGSS\] of 3 \[moderate\] or 4 \[severe\]).

Timeline

Start
2015-11-04
Primary completion
2017-02-23
Completion
2017-02-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Tretinoin Small molecule 0.05 % Topical

Indications